-
News
| Health
As the justices prepare to hear arguments in the Myriad Genetics case, observers are debating the impact of the outcome on personalized medicine and whole-genome sequencing
By
Heidi Ledford
and
Nature magazine
|
Apr 11, 2013 |
-
News
| Health
The new therapy for acute lymphoblastic leukemia, a swift-growing cancer that tends to kill more than 60 percent of those afflicted, involves extracting T cells and modifying them to home in on and destroy B cells in healthy and cancerous tissue
By
Heidi Ledford
and
Nature magazine
|
Mar 21, 2013 |
-
News
| Health
New evidence suggests the mechanism of action for a red wine compound that some say is linked to a longer life span. Resveratrol acts directly on a protein that has been linked to cell metabolism and inflammatory diseases
By
Heidi Ledford
and
Nature magazine
|
Mar 8, 2013 |
-
News
| Health
Revised guidelines for heart health are set to move away from target-based approach
By
Heidi Ledford
|
Feb 26, 2013 |
-
News
| Health
The agency's approval of the first seasonal flu vaccine made of recombinant proteins rather than inactivated or weakened virus comes as emergency rooms are clogged with victims of an early and severe flu season
By
Heidi Ledford
and
Nature News Blog
|
Jan 22, 2013 |
-
News
| More Science
Congress's decision on January 1 to delay mandatory cuts to agencies, including the NIH and NSF, means administrators must still plan for possible plunges in funding for medical schools and other campuses
By
Heidi Ledford
and
Nature magazine
|
Jan 3, 2013 |
-
News
| Health
The drug industry says the antibiotic pipeline is blocked by overly stringent clinical-trial requirements for new treatments
By
Heidi Ledford
and
Nature magazine
|
Dec 4, 2012 |
-
News
| Health
Critics say controversy over publication of mutant-H5N1 research highlights biosecurity weaknesses
By
Heidi Ledford
and
Nature magazine
|
Jan 3, 2012 |
-
News
| More Science
By
Heidi Ledford
and
Nature magazine
|
Aug 18, 2011 |